相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。From combinations to multitarget-directed ligands: A continuum in Alzheimer's disease polypharmacology
Claudia Albertini et al.
MEDICINAL RESEARCH REVIEWS (2021)
Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer's disease
Divya Goyal et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2021)
Beneficial Effects of Epigallocatechin-3-O-Gallate, Chlorogenic Acid, Resveratrol, and Curcumin on Neurodegenerative Diseases
Ryuuta Fukutomi et al.
MOLECULES (2021)
Topical Collection Pharmacology of Medicinal Plants
Barbara Romano et al.
BIOMOLECULES (2021)
Flavonoids: Potential Candidates for the Treatment of Neurodegenerative Disorders
Shweta Devi et al.
BIOMEDICINES (2021)
Emerging concepts in synucleinopathies
Tiago Fleming Outeiro
ACTA NEUROPATHOLOGICA (2021)
Accelerating Alzheimer's disease drug discovery and development: what's the way forward?
Bruno P. Imbimbo et al.
EXPERT OPINION ON DRUG DISCOVERY (2021)
Interleukin-1β mediates alterations in mitochondrial fusion/fission proteins and memory impairment induced by amyloid-β oligomers
Andre F. Batista et al.
JOURNAL OF NEUROINFLAMMATION (2021)
Natural products in drug discovery: advances and opportunities
Atanas G. Atanasov et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?
Diane L. Ritchie et al.
BIOMOLECULES (2021)
Sustainable Drug Discovery of Multi-Target-Directed Ligands for Alzheimer's Disease
Michele Rossi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Neuroprotective Herbs for the Management of Alzheimer's Disease
Julie Gregory et al.
BIOMOLECULES (2021)
Pentameric Thiophene as a Probe to Monitor EGCG's Remodeling Activity of Mature Amyloid Fibrils: Overcoming Signal Artifacts of Thioflavin T
Mirian Kelley et al.
ACS OMEGA (2021)
Natural Products and Their Bioactive Compounds: Neuroprotective Potentials against Neurodegenerative Diseases
Nur Shafika Mohd Sairazi et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2020)
Synucleinopathies: Where we are and where we need to go
Ines Caldeira Bras et al.
JOURNAL OF NEUROCHEMISTRY (2020)
Epigallocatechin-3-Gallate (EGCG) Improves Cognitive Deficits Aggravated by an Obesogenic Diet Through Modulation of Unfolded Protein Response in APPswe/PS1dE9 Mice
Miren Ettcheto et al.
MOLECULAR NEUROBIOLOGY (2020)
Invited Review: The role of prion-like mechanisms in neurodegenerative diseases
Z. Jaunmuktane et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2020)
Protective Effect of (-)Epigallocatechin-3-gallate on Rotenone-Induced Parkinsonism-like Symptoms in Rats
Hsiang-Chien Tseng et al.
NEUROTOXICITY RESEARCH (2020)
The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration
Anne-Laure Mahul-Mellier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Parkinson's disease: From bench to bedside
A. Draoui et al.
REVUE NEUROLOGIQUE (2020)
An Overview of Crucial Dietary Substances and Their Modes of Action for Prevention of Neurodegenerative Diseases
Lea Pogacnik et al.
CELLS (2020)
Targeting α-Synuclein for PD Therapeutics: A Pursuit on All Fronts
Margaux Teil et al.
BIOMOLECULES (2020)
EGCG ameliorates neuronal and behavioral defects by remodeling gut microbiota and TotM expression in Drosophila models of Parkinson's disease
Yi Xu et al.
FASEB JOURNAL (2020)
Oligomers Are Promising Targets for Drug Development in the Treatment of Proteinopathies
Oxana Galzitskaya
FRONTIERS IN MOLECULAR NEUROSCIENCE (2020)
Editorial: Protein Misfolding and Spreading Pathology in Neurodegenerative Diseases
Diana F. Lazaro et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2020)
The Aggregation Conditions Define Whether EGCG is an Inhibitor or Enhancer of α-Synuclein Amyloid Fibril Formation
Rebecca Sternke-Hoffmann et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
David J. Newman et al.
JOURNAL OF NATURAL PRODUCTS (2020)
Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer's Disease
Md. Sahab Uddin et al.
MOLECULES (2020)
Impact of Natural Compounds on Neurodegenerative Disorders: From Preclinical to Pharmacotherapeutics
Mehdi Sharifi-Rad et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Protein transmission in neurodegenerative disease
Chao Peng et al.
NATURE REVIEWS NEUROLOGY (2020)
Should drug discovery scientists still embrace the amyloid hypothesis for Alzheimer's disease or should they be looking elsewhere?
Bruno Pietro Imbimbo et al.
EXPERT OPINION ON DRUG DISCOVERY (2020)
Multitarget Therapeutics for Neurodegenerative Diseases
Moustafa T. Gabr et al.
BIOMED RESEARCH INTERNATIONAL (2020)
Multitarget Therapeutic Strategies for Alzheimer's Disease: Review on Emerging Target Combinations
Samuele Maramai et al.
BIOMED RESEARCH INTERNATIONAL (2020)
Green Tea Polyphenol Microparticles Based on the Oxidative Coupling of EGCG Inhibit Amyloid Aggregation/Cytotoxicity and Serve as a Platform for Drug Delivery
Luiza Fernandes et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2020)
Neuroprotection: Targeting Multiple Pathways by Naturally Occurring Phytochemicals
Andleeb Khan et al.
BIOMEDICINES (2020)
Potential Role of Natural Polyphenols against Protein Aggregation Toxicity: In Vitro, In Vivo, and Clinical Studies
Gabriela Henriquez et al.
ACS CHEMICAL NEUROSCIENCE (2020)
Developing Therapies for Neurodegenerative Disorders: Insights from Protein Aggregation and Cellular Stress Responses
Giovanna R. Mallucci et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 36, 2020 (2020)
Inhibition of Aβ aggregates in Alzheimer's disease by epigallocatechin and epicatechin-3-gallate from green tea
Tingting Chen et al.
BIOORGANIC CHEMISTRY (2020)
Catechins as Tools to Understand the Molecular Basis of Neurodegeneration
Karla Martinez Pomier et al.
MOLECULES (2020)
Synergy between amyloid-β and tau in Alzheimer's disease
Marc Aurel Busche et al.
NATURE NEUROSCIENCE (2020)
Progress toward Alzheimer's disease treatment: Leveraging the Achilles' heel of Aβ oligomers?
Jacques Fantini et al.
PROTEIN SCIENCE (2020)
EGCG impedes human Tau aggregation and interacts with Tau
Shweta Kishor Sonawane et al.
SCIENTIFIC REPORTS (2020)
Reciprocal Interactions between Epigallocatechin-3-gallate (EGCG) and Human Gut Microbiota In Vitro
Zhibin Liu et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2020)
Target Dysbiosis of Gut Microbes as a Future Therapeutic Manipulation in Alzheimer's Disease
Feiqi Zhu et al.
FRONTIERS IN AGING NEUROSCIENCE (2020)
Distinguishing the Effect on the Rate and Yield of Aβ42 Aggregation by Green Tea Polyphenol EGCG
Giovanna Park et al.
ACS OMEGA (2020)
Marine Natural Products, Multitarget Therapy and Repurposed Agents in Alzheimer's Disease
Marcia Martins et al.
PHARMACEUTICALS (2020)
The Role of α-Synuclein Oligomers in Parkinson's Disease
Xiao-yu Du et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Therapeutic Strategies to Reduce the Toxicity of Misfolded Protein Oligomers
Ryan P. Kreiser et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The pharmacological activity of epigallocatechin-3-gallate (EGCG) on Alzheimer's disease animal model: A systematic review
Shuang Zhang et al.
PHYTOMEDICINE (2020)
Natural Compounds as Inhibitors of Aβ Peptide Aggregation: Chemical Requirements and Molecular Mechanisms
Katiuscia Pagano et al.
FRONTIERS IN NEUROSCIENCE (2020)
Editorial: Oxidative Stress: How Has It Been Considered in the Design of New Drug Candidates for Neurodegenerative Diseases?
Claudio Viegas et al.
FRONTIERS IN PHARMACOLOGY (2020)
Modeling Parkinson's Disease Neuropathology and Symptoms by Intranigral Inoculation of Preformed Human α-Synuclein Oligomers
Laura Boi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Insights from nature: A review of natural compounds that target protein misfolding in vivo
Cassandra Terry
CURRENT RESEARCH IN BIOTECHNOLOGY (2020)
Alzheimer's disease drug development pipeline: 2020
Jeffrey Cummings et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2020)
Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2020
Kevin McFarthing et al.
JOURNAL OF PARKINSONS DISEASE (2020)
2020 Alzheimer's disease facts and figures
[Anonymous]
ALZHEIMERS & DEMENTIA (2020)
α-Synuclein misfolding and aggregation: Implications in Parkinson's disease pathogenesis
Surabhi Mehra et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2019)
Multi-target natural products as alternatives against oxidative stress in Chronic Obstructive Pulmonary Disease (COPD)
Priscila Baltazar Goncalves et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Multitarget-directed ligands for neurodegenerative diseases: real opportunity or blurry mirage?
Mohamed Benchekroun et al.
FUTURE MEDICINAL CHEMISTRY (2019)
Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Valery L. Feigin et al.
LANCET NEUROLOGY (2019)
Special Issue: The Antioxidant Capacities of Natural Products
Susana M. Cardoso
MOLECULES (2019)
Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis
Archana Prasad et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
Plant Extracts and Phytochemicals Targeting α-Synuclein Aggregation in Parkinson's Disease Models
Hayate Javed et al.
FRONTIERS IN PHARMACOLOGY (2019)
Simulation Studies of Amyloidogenic Polypeptides and Their Aggregates
Ioana M. Ilie et al.
CHEMICAL REVIEWS (2019)
The prion-like propagation hypothesis in Alzheimer's and Parkinson's disease
Charles Duyckaerts et al.
CURRENT OPINION IN NEUROLOGY (2019)
The current status of pharmacotherapy for the treatment of Parkinson's disease: transition from single-target to multitarget therapy
Siew L. Cheong et al.
DRUG DISCOVERY TODAY (2019)
Toward the discovery and development of effective modulators of α-synuclein amyloid aggregation
Valentina Oliveri
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model
Amanda Cano et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Oxidative Stress: A Key Modulator in Neurodegenerative Diseases
Anju Singh et al.
MOLECULES (2019)
Do Catechins (ECG and EGCG) Bind to the Same Site as Thioflavin T (ThT) in Amyloid Fibril? Answer From Saturation Transfer Difference NMR
Dipanwita Roy et al.
NATURAL PRODUCT COMMUNICATIONS (2019)
The Potential of Flavonoids for the Treatment of Neurodegenerative Diseases
Pamela Maher
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Alpha-synuclein structure and Parkinson's disease - lessons and emerging principles
Richard M. Meade et al.
MOLECULAR NEURODEGENERATION (2019)
Diverse Misfolded Conformational Strains and Cross-seeding of Misfolded Proteins Implicated in Neurodegenerative Diseases
Kwang Hun Lim
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression
Xinyi Wang et al.
CELL RESEARCH (2019)
Protein misfolding, aggregation and mechanism of amyloid cytotoxicity: An overview and therapeutic strategies to inhibit aggregation
Masihuz Zaman et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2019)
The Role of Protein Misfolding and Tau Oligomers (TauOs) in Alzheimer's Disease (AD)
Barbara Mroczko et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial
Johannes Levin et al.
LANCET NEUROLOGY (2019)
Complex of EGCG with Cu(II) Suppresses Amyloid Aggregation and Cu(II)-Induced Cytotoxicity of α-Synuclein
Yilong Teng et al.
MOLECULES (2019)
Ageing as a risk factor for neurodegenerative disease
Yujun Hou et al.
NATURE REVIEWS NEUROLOGY (2019)
Neuroinflammation as a Common Feature of Neurodegenerative Disorders
Leonardo Guzman-Martinez et al.
FRONTIERS IN PHARMACOLOGY (2019)
Natural Products in Neurodegenerative Diseases: A Great Promise but an Ethical Challenge
Marco Di Paolo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Cryo-EM structure and polymorphism of Aβ amyloid fibrils purified from Alzheimer's brain tissue
Marius Kollmer et al.
NATURE COMMUNICATIONS (2019)
Prion-Like Propagation of Protein Misfolding and Aggregation in Amyotrophic Lateral Sclerosis
Luke McAlary et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
New approaches for the treatment of Alzheimer's disease
Paul V. Fish et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Air pollution and Parkinson's disease: A systematic review and meta-analysis up to 2018
Maria-Iosifina Kasdagli et al.
INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH (2019)
Living in Promiscuity: The Multiple Partners of Alpha-Synuclein at the Synapse in Physiology and Pathology
Francesca Longhena et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Combined treatment with the phenolics (-)-epigallocatechin-3-gallate and ferulic acid improves cognition and reduces Alzheimer-like pathology in mice
Takashi Mori et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Emma Nichols et al.
LANCET NEUROLOGY (2019)
A critical appraisal of amyloid-βtargeting therapies for Alzheimer disease
Francesco Panza et al.
NATURE REVIEWS NEUROLOGY (2019)
Structural features distinguishing infectious ex vivo mammalian prions from non-infectious fibrillar assemblies generated in vitro
Cassandra Terry et al.
SCIENTIFIC REPORTS (2019)
Phytotherapy in treatment of Parkinson's disease: a review
Zahra Rabiei et al.
PHARMACEUTICAL BIOLOGY (2019)
Challenges and Opportunities in Central Nervous System Drug Discovery
Jonathan J. Danon et al.
TRENDS IN CHEMISTRY (2019)
BACE-1 and γ-Secretase as Therapeutic Targets for Alzheimer's Disease
Miguel A. Maia et al.
PHARMACEUTICALS (2019)
Alzheimer's disease
C. A. Lane et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases
Michael G. Erkkinen et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2018)
Inhibition of protein misfolding and aggregation by natural phenolic compounds
Zohra Dhouafli et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2018)
Therapeutic strategies for targeting neurodegenerative protein misfolding disorders
Robert H. Scannevin
CURRENT OPINION IN CHEMICAL BIOLOGY (2018)
Determinants of dopaminergic neuron loss in Parkinson's disease
Dalton James Surmeier
FEBS JOURNAL (2018)
The polypharmacology of natural products
Tu T. Ho et al.
FUTURE MEDICINAL CHEMISTRY (2018)
Multifactorial Hypothesis and Multi-Targets for Alzheimer's Disease
Cheng-Xin Gong et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
(-)-Epigallocatechin-3-gallate modulates peripheral immunity in the MPTP-induced mouse model of Parkinson's disease
Tingting Zhou et al.
MOLECULAR MEDICINE REPORTS (2018)
Epigallocatechin Gallate Reduces Amyloid beta-Induced Neurotoxicity via Inhibiting Endoplasmic Reticulum Stress-Mediated Apoptosis
Ke Du et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2018)
Beneficial Effects of Green Tea Catechins on Neurodegenerative Diseases
Monira Pervin et al.
MOLECULES (2018)
BACE failures lower AD expectations, again
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2018)
Prions, prionoids and protein misfolding disorders
Claudia Scheckel et al.
NATURE REVIEWS GENETICS (2018)
The 200-year journey of Parkinson disease: Reflecting on the past and looking towards the future
Stanley Fahn
PARKINSONISM & RELATED DISORDERS (2018)
Neuropathology of Parkinson disease
Dennis W. Dickson
PARKINSONISM & RELATED DISORDERS (2018)
Amyloid toxicity in Alzheimer's disease
Allison B. Reiss et al.
REVIEWS IN THE NEUROSCIENCES (2018)
Alpha-Synuclein: From Early Synaptic Dysfunction to Neurodegeneration
Veronica Ghiglieri et al.
FRONTIERS IN NEUROLOGY (2018)
Alzheimer's disease hypothesis and related therapies
Xiaoguang Du et al.
TRANSLATIONAL NEURODEGENERATION (2018)
Bioavailability of Tea Catechins and Its Improvement
Zhuo-Yu Cai et al.
MOLECULES (2018)
Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases
Claudio Soto et al.
NATURE NEUROSCIENCE (2018)
Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases
Mathias Jucker et al.
NATURE NEUROSCIENCE (2018)
Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs
Delphine Charvin et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
A new era for understanding amyloid structures and disease
Matthew G. Iadanza et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
EGCG Nanoparticles Attenuate Aluminum Chloride Induced Neurobehavioral Deficits, Beta Amyloid and Tau Pathology in a Rat Model of Alzheimer's Disease
Neha Atulkumar Singh et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
Parkinson's Disease: Biomarkers, Treatment, and Risk Factors
Fatemeh N. Emamzadeh et al.
FRONTIERS IN NEUROSCIENCE (2018)
Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
E. Ray Dorsey et al.
LANCET NEUROLOGY (2018)
The Potential Use of Plant Natural Products and Plant Extracts with Antioxidant Properties for the Prevention/Treatment of Neurodegenerative Diseases: In Vitro, In Vivo and Clinical Trials
Franziska Pohl et al.
MOLECULES (2018)
A perspective on multi-target drug discovery and design for complex diseases
Rona R. Ramsay et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2018)
Antioxidants from black and green tea: from dietary modulation of oxidative stress to pharmacological mechanisms
Ilaria Peluso et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Gut microbiota composition in relation to the metabolic response to 12-week combined polyphenol supplementation in overweight men and women
J. Most et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2017)
Dietary Modulation of Oxidative Stress in Alzheimer's Disease
Arjun Thapa et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Protein aggregation, misfolding and consequential human neurodegenerative diseases
Neha Sami et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2017)
Epigallocatechin Gallate Has a Neurorescue Effect in a Mouse Model of Parkinson Disease
Qi Xu et al.
JOURNAL OF NUTRITION (2017)
Molecular Mechanism for the (-)-Epigallocatechin Gallate-Induced Toxic to Nontoxic Remodeling of Aβ Oligomers
Rashik Ahmed et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2017)
Effects of medicinal plants on Alzheimer's disease and memory deficits
Muhammad Akram et al.
NEURAL REGENERATION RESEARCH (2017)
The need for new approaches in CNS drug discovery: Why drugs have failed, and what can be done to improve outcomes
Valentin K. Gribkoff et al.
NEUROPHARMACOLOGY (2017)
(-)-Epigallocatechin-3-gallate ameliorates memory impairment and rescues the abnormal synaptic protein levels in the frontal cortex and hippocampus in a mouse model of Alzheimer's disease
Yufang Guo et al.
NEUROREPORT (2017)
Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications
Zewen Liu et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease
Reisuke H. Takahashi et al.
PATHOLOGY INTERNATIONAL (2017)
Pathology of Neurodegenerative Diseases
Brittany N. Dugger et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)
Two decades of new drug discovery and development for Alzheimer's disease
Zhidong Liu et al.
RSC ADVANCES (2017)
(-)-Epigallocatechin-3-gallate (EGCG) inhibits fibrillation, disaggregates amyloid fibrils of alpha-synuclein, and protects PC12 cells against alpha-synuclein-induced toxicity
Juan Zhao et al.
RSC ADVANCES (2017)
The Synucleinopathies: Twenty Years On
Michel Goedert et al.
JOURNAL OF PARKINSONS DISEASE (2017)
The efficacy of Epigallocatechin-3-gallate (green tea) in the treatment of Alzheimer's disease: an overview of pre-clinical studies and translational perspectives in clinical practice
Marco Cascella et al.
INFECTIOUS AGENTS AND CANCER (2017)
Protein misfolding in neurodegenerative diseases: implications and strategies
Patrick Sweeney et al.
TRANSLATIONAL NEURODEGENERATION (2017)
Short-term air pollution exposure aggravates Parkinson's disease in a population-based cohort
Hyewon Lee et al.
SCIENTIFIC REPORTS (2017)
EGCG-mediated Protection of the Membrane Disruption and Cytotoxicity Caused by the 'Active Oligomer' of α-Synuclein
Jee Eun Yang et al.
SCIENTIFIC REPORTS (2017)
Comparison of α-Synuclein Fibril Inhibition by Four Different Amyloid Inhibitors
Narendra Nath Jha et al.
ACS CHEMICAL NEUROSCIENCE (2017)
Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease
Alexandre Bejanin et al.
BRAIN (2017)
Comparison of disaggregative effect of A-type EGCG dimer and EGCG monomer on the preformed bovine insulin amyloid fibrils
Rong-zu Nie et al.
BIOPHYSICAL CHEMISTRY (2017)
Important medicinal herbs in Parkinson's disease pharmacotherapy
Saurabh Srivastav et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Parkinson's disease and pesticides: A meta-analysis of disease connection and genetic alterations
Hussien Ahmed et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Curcumin Attenuates Arnyloid-β Aggregate Toxicity and Modulates Amyloid-β Aggregation Pathway
Arjun Thapa et al.
ACS CHEMICAL NEUROSCIENCE (2016)
Structure, function and toxicity of alpha-synuclein: the Bermuda triangle in synucleinopathies
Anna Villar-Pique et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG)
Neha Atulkumar Singh et al.
NUTRITION JOURNAL (2016)
Neurodegenerative disorders share common features of loss of function states of a proposed mechanism of nervous system functions
Kunjumon I. Vadakkan
BIOMEDICINE & PHARMACOTHERAPY (2016)
Protective role of epigallocatechin-3-gallate in health and disease: A perspective
Animesh Chowdhury et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease
Timothy R. Sampson et al.
CELL (2016)
Epigallocatechin gallate attenuates amyloid β-induced inflammation and neurotoxicity in EOC 13.31 microglia
James Cheng-Chung Wei et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Protein Misfolding in Prion and Prion-Like Diseases: Reconsidering a Required Role for Protein Loss-of-Function
Patricia L. A. Leighton et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
The World report on ageing and health: a policy framework for healthy ageing
John R. Beard et al.
LANCET (2016)
Structural disorder of monomeric α-synuclein persists in mammalian cells
Francois-Xavier Theillet et al.
NATURE (2016)
Neurodegenerative diseases: From available treatments to prospective herbal therapy
Isha Solanki et al.
NEUROCHEMISTRY INTERNATIONAL (2016)
Neurodegenerative Diseases: Expanding the Prion Concept
Lary C. Walker et al.
ANNUAL REVIEW OF NEUROSCIENCE, VOL 38 (2015)
Neuroprotective Properties of the Standardized Extract from Camellia sinensis (Green Tea) and Its Main Bioactive Components, Epicatechin and Epigallocatechin Gallate, in the 6-OHDA Model of Parkinson's Disease
Natalia Bitu Pinto et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2015)
(-)-Epigallocatechin-3-gallate attenuates cognitive deterioration in Alzheimer's disease model mice by upregulating neprilysin expression
Xiang Chang et al.
EXPERIMENTAL CELL RESEARCH (2015)
Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer's disease
Sergio T. Ferreira et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
EGCG Protects against 6-OHDA-Induced Neurotoxicity in a Cell Culture Model
Dan Chen et al.
PARKINSONS DISEASE (2015)
Alzheimer's disease
Colin L. Masters et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
The green tea polyphenol (-)-epigallocatechin gallate prevents the aggregation of tau protein into toxic oligomers at substoichiometric ratios
Heike J. Wobst et al.
FEBS LETTERS (2015)
Beneficial Effects of Dietary EGCG and Voluntary Exercise on Behavior in an Alzheimer's Disease Mouse Model
Jennifer M. Walker et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
The behavioral, pathological and therapeutic features of the senescence-accelerated mouse prone 8 strain as an Alzheimer's disease animal model
Xiao-rui Cheng et al.
AGEING RESEARCH REVIEWS (2014)
Therapeutic approaches against common structural features of toxic oligomers shared by multiple amyloidogenic proteins
Marcos J. Guerrero-Munoz et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Differences between amyloid-beta aggregation in solution and on the membrane: insights into elucidation of the mechanistic details of Alzheimer's disease
Samuel A. Kotler et al.
CHEMICAL SOCIETY REVIEWS (2014)
Natural Compounds against Neurodegenerative Diseases: Molecular Characterization of the Interaction of Catechins from Green Tea with Aβ1-42, PrP106-126, and Ataxin-3 Oligomers
Erika Sironi et al.
CHEMISTRY-A EUROPEAN JOURNAL (2014)
Multi-target approach for natural products in inflammation
Andreas Koeberle et al.
DRUG DISCOVERY TODAY (2014)
How Epigallocatechin Gallate Can Inhibit α-Synuclein Oligomer Toxicity in Vitro
Nikolai Lorenzen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
The hairpin conformation of the amyloid β peptide is an important structural motif along the aggregation pathway
Axel Abelein et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2014)
Parkinson's disease: animal models and dopaminergic cell vulnerability
Javier Blesa et al.
FRONTIERS IN NEUROANATOMY (2014)
Amyloid-β and Tau The Trigger and Bullet in Alzheimer Disease Pathogenesis
George S. Bloom
JAMA NEUROLOGY (2014)
Curcumin Modulates α-Synuclein Aggregation and Toxicity
Pradeep K. Singh et al.
ACS CHEMICAL NEUROSCIENCE (2013)
Biology and Genetics of Prions Causing Neurodegeneration
Stanley B. Prusiner
ANNUAL REVIEW OF GENETICS, VOL 47 (2013)
Green tea (-)epigallocatechin-3-gallate reverses oxidative stress and reduces acetylcholinesterase activity in a streptozotocin-induced model of dementia
Regina Biasibetti et al.
BEHAVIOURAL BRAIN RESEARCH (2013)
Epigallocatechin-3-gallate prevents systemic inflammation-induced memory deficiency and amyloidogenesis via its anti-neuroinflammatory properties
Young-Jung Lee et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2013)
Biocompatible, Functional Spheres Based on Oxidative Coupling Assembly of Green Tea Polyphenols
Zhenhua Chen et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
Toward the Molecular Mechanism(s) by Which EGCG Treatment Remodels Mature Amyloid Fibrils
Fernando L. Palhano et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
The many faces of alpha-synuclein: from structure and toxicity to therapeutic target
Hilal A. Lashuel et al.
NATURE REVIEWS NEUROSCIENCE (2013)
Polyphenols: Multipotent Therapeutic Agents in Neurodegenerative Diseases
Khushwant S. Bhullar et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2013)
Alternative Pathways of Human Islet Amyloid Polypeptide Aggregation Distinguished by 19F Nuclear Magnetic Resonance-Detected Kinetics of Monomer Consumption
Yuta Suzuki et al.
BIOCHEMISTRY (2012)
Epigallocatechin-3-gallate suppresses 1-methyl-4-phenyl-pyridine-induced oxidative stress in PC12 cells via the SIRT1/PGC-1α signaling pathway
Qinyong Ye et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2012)
Protein Misfolded Oligomers: Experimental Approaches, Mechanism of Formation, and Structure-Toxicity Relationships
Francesco Bemporad et al.
CHEMISTRY & BIOLOGY (2012)
Role of α-synuclein penetration into the membrane in the mechanisms of oligomer pore formation
Igor F. Tsigelny et al.
FEBS JOURNAL (2012)
Conformational Differences between Two Amyloid β Oligomers of Similar Size and Dissimilar Toxicity
Ali Reza A. Ladiwala et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
α-Synuclein in Central Nervous System and from Erythrocytes, Mammalian Cells, and Escherichia coli Exists Predominantly as Disordered Monomer
Bruno Fauvet et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Structural Properties of EGCG-Induced, Nontoxic Alzheimer's Disease Aβ Oligomers
Juan Miguel Lopez del Amo et al.
JOURNAL OF MOLECULAR BIOLOGY (2012)
Epigallocatechin-3-Gallate as a Potential Therapeutic Drug for TTR-Related Amyloidosis: In Vivo Evidence from FAP Mice Models
Nelson Ferreira et al.
PLOS ONE (2012)
Inhibition and disaggregation of α-synuclein oligomers by natural polyphenolic compounds
Mario Caruana et al.
FEBS LETTERS (2011)
α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation
Tim Bartels et al.
NATURE (2011)
The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease
Sergio T. Ferreira et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2011)
In vivo demonstration that α-synuclein oligomers are toxic
Beate Winner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
ANS Binding Reveals Common Features of Cytotoxic Amyloid Species
Benedetta Bolognesi et al.
ACS CHEMICAL BIOLOGY (2010)
Effects of epigallocatechin gallate on rotenone-injured murine brain cultures
Rudolf Moldzio et al.
JOURNAL OF NEURAL TRANSMISSION (2010)
(-)-Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, reduces dichlorodiphenyl-trichloroethane (DDT)-induced cell death in dopaminergic SHSY-5Y cells
Kwok-Keung Tai et al.
NEUROSCIENCE LETTERS (2010)
EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity
Jan Bieschke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Neuroprotective effect of epigallocatechin-3-gallate against β-amyloid-induced oxidative and nitrosative cell death via augmentation of antioxidant defense capacity
Chang-Yul Kim et al.
ARCHIVES OF PHARMACAL RESEARCH (2009)
Neuroprotective Effects of (-)-Epigallocatechin-3-gallate on Aging Mice Induced by D-Galactose
Miao He et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2009)
(-)-Epigallocatechin-3-gallate prevents lipopolysaccharide-induced elevation of beta-amyloid generation and memory deficiency
Young Kyoung Lee et al.
BRAIN RESEARCH (2009)
Binding of epigallocatechin-3-gallate to transthyretin modulates its amyloidogenicity
Nelson Ferreira et al.
FEBS LETTERS (2009)
Effect of lycopene and epigallocatechin-3-gallate against 3-nitropropionic acid induced cognitive dysfunction and glutathione depletion in rat: A novel nitric oxide mechanism
Puneet Kumar et al.
FOOD AND CHEMICAL TOXICOLOGY (2009)
(-)-Epigallocatechin-3-Gallate Protects SH-SY5Y Cells Against 6-OHDA-Induced Cell Death through STAT3 Activation
Lili Wang et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Green Tea (-)-Epigallocatechin-3-Gallate Inhibits β-Amyloid-Induced Cognitive Dysfunction through Modification of Secretase Activity via Inhibition of ERK and NF-κB Pathways in Mice
Jae Woong Lee et al.
JOURNAL OF NUTRITION (2009)
Epigallocatechin gallate (EGCG) suppresses beta-amyloid-induced neurotoxicity through inhibiting c-Abl/FE65 nuclear translocation and GSK3 beta activation
Chih-Li Lin et al.
NEUROBIOLOGY OF AGING (2009)
Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation
Ying Feng et al.
NEUROTOXICOLOGY (2009)
Green tea epigallocatechin-3-gallate (EGCG) reduces β-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice
Kavon Rezai-Zadeh et al.
BRAIN RESEARCH (2008)
Neuroprotective effects of (-)-epigallocatechin-3-gallate (EGCG) on paraquat-induced apoptosis in PC12 cells
Rong-Rong Hou et al.
CELL BIOLOGY INTERNATIONAL (2008)
EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers
Dagmar E. Ehrnhoefer et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
Epigallocatechin-3-gallate and curcumin suppress amyloid beta-induced beta-site APP cleaving enzyme-1 upregulation
Yoshiari Shimmyo et al.
NEUROREPORT (2008)
Early kinetics of amyloid fibril formation reveals conformational reorganisation of initial aggregates
N. Cerda-Costa et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Neuroprotective effects of (-)-epigallocatechin-3-gallate in a transgenic mouse model of amyotrophic lateral sclerosis
Zhihao Xu et al.
NEUROCHEMICAL RESEARCH (2006)
Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models
Dagmar E. Ehrnhoefer et al.
HUMAN MOLECULAR GENETICS (2006)
The effect of epigallocatechin gallate on suppressing disease progression of ALS model mice
SH Koh et al.
NEUROSCIENCE LETTERS (2006)
Stability of tea polyphenol (-)-epigallocatechin-3-gallate and formation of dimers and epimers under common experimental conditions
SM Sang et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2005)
Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice
K Rezai-Zadeh et al.
JOURNAL OF NEUROSCIENCE (2005)
Unfolding the role of protein misfolding in neurodegenerative diseases
C Soto
NATURE REVIEWS NEUROSCIENCE (2003)
α-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils
HA Lashuel et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)
Prevention of nitric oxide-mediated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease in mice by tea phenolic epigallocatechin 3-gallate
JY Choi et al.
NEUROTOXICOLOGY (2002)
Oxidative stress increases expression and activity of BACE in NT2 neurons
E Tamagno et al.
NEUROBIOLOGY OF DISEASE (2002)
Neurodegenerative disease - Amyloid pores from pathogenic mutations
HA Lashuel et al.
NATURE (2002)
The green tea polyphenol (-)-epigallocatechin gallate attenuates β-amyloid-induced neurotoxicity in cultured hippocampal neurons
YT Choi et al.
LIFE SCIENCES (2001)
Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration
Y Levites et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
R Betarbet et al.
NATURE NEUROSCIENCE (2000)
Review:: Alzheimer's amyloid β-peptide-associated free radical oxidative stress and neurotoxicity
S Varadarajan et al.
JOURNAL OF STRUCTURAL BIOLOGY (2000)
分享论文
